ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Abingworth Bioventures Iii GP Limited

Abingworth Bioventures Iii GP Limited is an active company incorporated on 20 September 2000 with the registered office located in Edinburgh, City of Edinburgh. Abingworth Bioventures Iii GP Limited was registered 25 years ago.
Status
Active
Active since incorporation
Company No
SC211185
Private limited company
Scottish Company
Age
25 years
Incorporated 20 September 2000
Size
Micro
Turnover is under £1M
Balance sheet is under £500,000
Under 10 employees
Confirmation
Submitted
Dated 31 October 2025 (1 month ago)
Next confirmation dated 31 October 2026
Due by 14 November 2026 (11 months remaining)
Last change occurred 9 years ago
Accounts
Submitted
For period 1 Jul30 Jun 2024 (1 year)
Accounts type is Total Exemption Full
Next accounts for period 30 June 2025
Due by 31 March 2026 (3 months remaining)
Address
50 Lothian Road
Edinburgh
Midlothian
EH3 9WJ
Same address since incorporation
Telephone
Unreported
Email
Unreported
People
Officers
3
Shareholders
1
Controllers (PSC)
1
Director • Secretary • British • Lives in England • Born in Feb 1962
Director • British • Lives in England • Born in Sep 1979
Abingworth Management Holdings Limited
PSC
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Abingworth Bioventures Iv GP Limited
James Foster Abell and Balaji Muralidhar are mutual people.
Active
Abingworth Management Limited
Balaji Muralidhar is a mutual person.
Active
Abingworth Management Holdings Limited
Balaji Muralidhar is a mutual person.
Active
BBB Investment Holdings Limited
Balaji Muralidhar is a mutual person.
Active
Cytospire Therapeutics Limited
Balaji Muralidhar is a mutual person.
Active
Abingworth LLP
Balaji Muralidhar is a mutual person.
Active
Financials
Net Assets, Total Assets & Total Liabilities (2015–2024)
Period Ended
30 Jun 2024
For period 30 Jun30 Jun 2024
Traded for 12 months
Cash in Bank
£3.49K
Decreased by £207 (-6%)
Turnover
Unreported
Same as previous period
Employees
Unreported
Same as previous period
Total Assets
£3.58K
Decreased by £207 (-5%)
Total Liabilities
£0
Same as previous period
Net Assets
£3.58K
Decreased by £207 (-5%)
Debt Ratio (%)
0%
Same as previous period
Latest Activity
Confirmation Submitted
23 Days Ago on 13 Nov 2025
Mr James Foster Abell Appointed
4 Months Ago on 29 Jul 2025
Mr James Foster Abell Appointed
4 Months Ago on 29 Jul 2025
John Grayson Heard Resigned
4 Months Ago on 29 Jul 2025
John Grayson Heard Resigned
4 Months Ago on 29 Jul 2025
Dr Balaji Muralidhar Appointed
8 Months Ago on 25 Mar 2025
Neil Antony Cooper Resigned
8 Months Ago on 25 Mar 2025
Full Accounts Submitted
10 Months Ago on 23 Jan 2025
Confirmation Submitted
1 Year Ago on 13 Nov 2024
Full Accounts Submitted
1 Year 8 Months Ago on 27 Mar 2024
Get Credit Report
Discover Abingworth Bioventures Iii GP Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Confirmation statement made on 31 October 2025 with no updates
Submitted on 13 Nov 2025
Appointment of Mr James Foster Abell as a director on 29 July 2025
Submitted on 4 Aug 2025
Termination of appointment of John Grayson Heard as a director on 29 July 2025
Submitted on 1 Aug 2025
Appointment of Mr James Foster Abell as a secretary on 29 July 2025
Submitted on 1 Aug 2025
Termination of appointment of John Grayson Heard as a secretary on 29 July 2025
Submitted on 1 Aug 2025
Termination of appointment of Neil Antony Cooper as a director on 25 March 2025
Submitted on 2 Apr 2025
Appointment of Dr Balaji Muralidhar as a director on 25 March 2025
Submitted on 2 Apr 2025
Total exemption full accounts made up to 30 June 2024
Submitted on 23 Jan 2025
Confirmation statement made on 31 October 2024 with no updates
Submitted on 13 Nov 2024
Total exemption full accounts made up to 30 June 2023
Submitted on 27 Mar 2024
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year